Eastman Chemical (EMN)
(Delayed Data from NYSE)
$100.22 USD
+0.64 (0.64%)
Updated Mar 28, 2024 04:00 PM ET
After-Market: $100.19 -0.03 (-0.03%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth D Momentum A VGM
Average Brokerage Rating
Current ABR | 2.09 |
ABR (Last week) | 2.09 |
# of Recs in ABR | 17 |
Average Target Price | $95.53 |
LT Growth Rate | 11.70% |
Industry | Chemical - Diversified |
Industry Rank by ABR | 188 of 252 |
Current Quarter EPS Est: | 1.43 |
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 7 | 7 | 7 | 6 | 6 |
Buy | 1 | 1 | 1 | 1 | 0 |
Hold | 9 | 9 | 9 | 9 | 10 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.09 | 2.09 | 2.09 | 2.16 | 2.25 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
12/15/2023 | Tudor Pickering Holt & Co. | Matthew Blair | Not Available | Strong Buy |
11/28/2023 | Mizuho SecuritiesUSA | John Roberts | Not Available | Hold |
10/31/2023 | KeyBanc Capital Markets | Aleksey Yefremov | Strong Buy | Strong Buy |
10/11/2023 | Piper Sandler | Charles N Neivert | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.